戻る
Onconetix Inc (ONCO)価格
ONCO 株価推移チャート
ONCO 収入
Onconetix Inc
$1.62
0.93%
$0.01
終値： Jan 16, 16:00:00 GMT-5
$1.55
-4.61%
$-0.07
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$1.61
始値
$1.6
当日レンジ
$1.48 - $1.63
52週レンジ
$1.37 - $88.4
取引高
10.8K
平均取引高
41.8K
1株当たり利益(TTM)
-342.64
配当利回り
--
時価総額
$2.4M
ONCOとは何ですか？
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company is headquartered in Cincinnati, Ohio and currently employs 5 full-time employees. The company went IPO on 2022-02-18. The firm owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.